Global and Japan Human Organs-on-Chip Market Report & Forecast 2023-2029

Global and Japan Human Organs-on-Chip Market Report & Forecast 2023-2029

Market Analysis and Insights: Global and Japan Human Organs-on-Chip Market

This report focuses on global and Japan Human Organs-on-Chip market, also covers the segmentation data of other regions in regional level and county level.

The global Human Organs-on-Chip revenue was at US$ 87.87 million in the year 2022, is projected to reach a revised size of US$ 621.29 million by 2029, growing at a CAGR of 31.21% during the forecast period 2023-2029.

In Japan the Human Organs-on-Chip revenue is expected to grow from US$ 6.63 million in 2022 to US$ 58.68 million by 2029, at a CAGR of 34.78% during the forecast period (2023-2029).

The global key players of Human Organs-on-Chip include Emulate, Mimetas, TissUse, Valo Health, CN Bio Innovations, Hesperos, Draper Laboratory, Nortis, and Micronit Microtechnologies B.V., etc. The global five biggest players hold a share of 58.32% in 2022.

Global Human Organs-on-Chip Scope and Market Size

Human Organs-on-Chip market is segmented in regional and country level, by players, by Type, and by End User. Players, stakeholders, and other participants in the global Human Organs-on-Chip market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by End User for the period 2018-2029.

For Japan market, this report focuses on the Human Organs-on-Chip market size by players, by Type, and by End User, for the period 2018-2029. The key players include the global and local players which play important roles in Japan.

By Company

Emulate

Mimetas

TissUse

Valo Health

CN Bio Innovations

Hesperos

Draper Laboratory

Nortis

Micronit Microtechnologies B.V.

Kirkstall

Cherry Biotech SAS

Else Kooi Laboratory

Altis Biosystems

Bi/ond

Netri

Xona Microfluidics

SynVivo

Beijing Daxiang Biotech

Segment by Type

Brain-on-a-chip

Liver-on-a-chip

Kidney-on-a-chip

Lung-on-a-chip

Heart-on-a-chip

Intestine-on-a-chip

Vessel-on-a-chip

Other Organs

Segment by End User

Pharmaceutical & Biotechnology Companies

Academic & Research Institutes

Cosmetics Industry

Others

By Region

Americas

United States

Canada

Mexico

Brazil

China

APAC (excluding China)

Japan

South Korea

China Taiwan

ASEAN

India

EMEA

Europe

Middle East

Africa

Chapter Introduction

Chapter 1: Introduces Human Organs-on-Chip definition, global market size, Japan market size, Japan percentage in global market. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.

Chapter 2: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 3: Provides the analysis of various market segments by End User, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 4: Detailed analysis of Human Organs-on-Chip companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Revenue of Human Organs-on-Chip in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 6: Americas by Type, by End User and by country, revenue for each segment.

Chapter 7: EMEA by Type, by End User and by region, revenue for each segment.

Chapter 8: China by Type, and by End User, revenue for each segment.

Chapter 9: APAC (excluding China) by Type, by End User and by region, revenue for each segment.

Chapter 10: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Human Organs-on-Chiprevenue, gross margin, and recent development, etc.

Chapter 11: Analyst's Viewpoints/Conclusions